Serplulimab
product
1 mentions
1 recordings
first heard Nov 2025
last heard 17 Nov
±0 this month
Serplulimab is a PD-1 checkpoint inhibitor developed by Fosun Pharma, used in lung cancer.
Trend
No mentions in the last 30d.Widen the range to see when Serplulimab was said.
Moments
newest first · ▶ plays the momentSam FazeliVanguards of Healthcare by Bloomberg Intelligence · Fosun Pharma’s Drive Beyond China · 21:31 · 17 Nov
…One of my favorite in the Henleus Fosun Pharma world is Serplulimab.…
All 1 moments